Uptitration of Drugs Varies With Target Dosage in Chronic HF
When target is higher versus lower dosage, uptitration stops further from recommended dosage
Read MoreOct 1, 2019
When target is higher versus lower dosage, uptitration stops further from recommended dosage
Read MoreOct 1, 2019
Odds of food insecurity up with reporting four or more chronic conditions, depression, anxiety
Read MoreOct 1, 2019
Updated meta-analysis shows lower risks for MI, CHD death, total CHD, CVD death, total CVD
Read MoreOct 1, 2019
Rates of both acute and chronic complications significantly increase with increasing HbA1c
Read MoreOct 1, 2019
Evidence insufficient to recommend primary care interventions to prevent, cut drug use in youth
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level of Red, […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Heart Disease May Up Risk for Allopurinol-Linked Cutaneous […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level of […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. CVS Halts Sales of OTC Zantac MONDAY, Sept. […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Average Annual Premium for Workers Increased […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. CDC Says People Can Contract Tuberculosis From […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Neurology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Recommendations Updated for Management of Pediatric ADHD MONDAY, […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Nursing for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level of Red, […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Infectious Disease Consultation May Lower Candida Mortality FRIDAY, […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Sports Specialization Ups Injury Risk, Especially in Girls […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Most Severe Forms of Mental Illness Lead to […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Surgery for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Adverse Outcomes Up for Vaginal Birth After Previous […]
Read MoreOct 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Urology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. SBRT Shortens Tx for Prostate Cancer Without Greater […]
Read More